Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2011 Oct 22;61(5):629–641. doi: 10.1007/s00262-011-1081-8

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Springer-Verlag 2011

PMC Copyright notice

Fig. 2 — ELISPOT analysis was performed using PBMCs obtained at the indicated time points post-vaccination against hTERT 988Y, her2/neu 369V2V9, 689, and PADRE for patients on Arm 1 (a), and Arm 2 or a single low dose of cyclophosphamide prior to IDD-6 (b). Responses to PMA and ionomycin from 5 × 103 cells are also shown; note scale difference. Longitudinal analysis was performed at baseline (−4 weeks) and post-vaccination. Composite plots for each peptide are also depicted with median values denoted by times symbol at each time point (c)

Fig. 2 — ELISPOT analysis was performed using PBMCs obtained at the indicated time points post-vaccination against hTERT 988Y, her2/neu 369V2V9, 689, and PADRE for patients on Arm 1 (a), and Arm 2 or a single low dose of cyclophosphamide prior to IDD-6 (b). Responses to PMA and ionomycin from 5 × 103 cells are also shown; note scale difference. Longitudinal analysis was performed at baseline (−4 weeks) and post-vaccination. Composite plots for each peptide are also depicted with median values denoted by times symbol at each time point (c)